FDA Adverse Event Malfunction Summary report: N

SOLYX SIS SYSTEM

MDR report key: 10615223 · Received October 1, 2020

Report

Report Number
3005099803-2020-04174
Event Type
Malfunction
Date Received
October 1, 2020
Date of Event
August 6, 2020
Report Date
October 29, 2020
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
PAH
PMA / PMN Number
K081275
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

BLOCKS D4, H4: THE REPORTED LOT NUMBER 2900492 DOES NOT PROVIDE A MATCH IN THE SYSTEM SEARCH; THEREFORE, THE DEVICE MANUFACTURE AND EXPIRATION DATES CANNOT BE DETERMINED. HOWEVER, THE COMPLAINANT REPORTED THAT THE DEVICE WAS NOT EXPIRED. BLOCK H6: DEVICE CODE 1484 CAPTURES THE REPORTABLE EVENT OF UNINTENDED RELEASE OF MESH CARRIER FROM SHAFT ASSEMBLY. CONCLUSION CODE 4316 IS BEING USED IN LIEU OF AN ADEQUATE CONCLUSION CODE FOR DEVICE NOT RETURNED. BLOCK H10: THE COMPLAINANT INDICATED THAT THE DEVICE WAS DISCARDED AND WILL NOT BE RETURNED FOR EVALUATION; THEREFORE, A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. IF ANY FURTHER RELEVANT INFORMATION IS IDENTIFIED, A SUPPLEMENTAL MEDWATCH WILL BE FILED.

Description of Event or Problem · 0

NOTE: THIS MANUFACTURER REPORT PERTAINS TO THE FIRST OF TWO DEVICES USED DURING THE SAME PROCEDURE. IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT TWO SOLYX DEVICES WERE USED DURING A SOLYX PLACEMENT FOR SUI PROCEDURE PERFORMED ON (B)(6) 2020 TO TREAT STRESS URINARY INCONTINENCE. ACCORDING TO THE COMPLAINANT, DURING THE INITIAL PLACEMENT ON (B)(6) 2020, THE MESH CARRIER DETACHED FROM THE SHAFT ASSEMBLY BEFORE THE PHYSICIAN COULD MAKE FINAL TENSIONING ADJUSTMENTS, AND HAD TO FORCEFULLY REMOVE THE SLING WHICH CAUSED TISSUE DAMAGE TO THE PATIENT. THE PHYSICIAN THEN OPENED A SECOND SOLYX DEVICE, BUT THE SAME ISSUE OCCURRED. HE THEN DECIDED TO NOT COMPLETE THE PROCEDURE AND LEAVE THE SLING TENSIONED A BIT TIGHTER THAN HE WANTED TO DECREASE TISSUE TRAUMA OF REMOVING AND REPLACING WITH ANOTHER SLING. THE PROCEDURE WAS COMPLETED IN A REVISION SURGERY ON (B)(6) 2020 WITH ANOTHER SOLYX DEVICE. ---ADDITIONAL INFORMATION RECEIVED ON OCTOBER 6, 2020--- THE REASON FOR THE REVISION SUGERY ON (B)(6) 2020 WAS NOT JUST TO REPLACE THE SLING BUT DUE TO THE PATIENT'S ADVERSE EVENT OF RETENTION AFTER THE SECOND SLING WAS LEFT IN PLACE.

Additional Manufacturer Narrative · 1

THE REPORTED LOT NUMBER 2900492 DOES NOT PROVIDE A MATCH IN THE SYSTEM SEARCH; THEREFORE, THE DEVICE MANUFACTURE AND EXPIRATION DATES CANNOT BE DETERMINED. HOWEVER, THE COMPLAINANT REPORTED THAT THE DEVICE WAS NOT EXPIRED. (B)(4). THE COMPLAINANT INDICATED THAT THE DEVICE WAS DISCARDED AND WILL NOT BE RETURNED FOR EVALUATION; THEREFORE, A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. IF ANY FURTHER RELEVANT INFORMATION IS IDENTIFIED, A SUPPLEMENTAL MEDWATCH WILL BE FILED.

Description of Event or Problem · 1

THIS MANUFACTURER REPORT PERTAINS TO THE FIRST OF TWO DEVICES USED DURING THE SAME PROCEDURE. IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT TWO SOLYX DEVICES WERE USED DURING A SOLYX PLACEMENT FOR SUI PROCEDURE PERFORMED ON (B)(6) 2020 TO TREAT STRESS URINARY INCONTINENCE. ACCORDING TO THE COMPLAINANT, DURING THE INITIAL PLACEMENT ON (B)(6) 2020, THE MESH CARRIER DETACHED FROM THE SHAFT ASSEMBLY BEFORE THE PHYSICIAN COULD MAKE FINAL TENSIONING ADJUSTMENTS, AND HAD TO FORCEFULLY REMOVE THE SLING WHICH CAUSED TISSUE DAMAGE TO THE PATIENT. THE PHYSICIAN THEN OPENED A SECOND SOLYX DEVICE, BUT THE SAME ISSUE OCCURRED. HE THEN DECIDED TO NOT COMPLETE THE PROCEDURE AND LEAVE THE SLING TENSIONED A BIT TIGHTER THAN HE WANTED TO DECREASE TISSUE TRAUMA OF REMOVING AND REPLACING WITH ANOTHER SLING. THE PROCEDURE WAS COMPLETED IN A REVISION SURGERY ON (B)(6) 2020 WITH ANOTHER SOLYX DEVICE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1082358 SOLYX SIS SYSTEM MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, FEMA PAH BOSTON SCIENTIFIC CORPORATION

Patients

Seq Age Sex Outcome Treatment
1 59 YR Required Intervention